| PDAC | Pancreatic ductal adenocarcinoma |
| USA | United States of America |
| FOLFIRINOX | Folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin |
| EGF | Epidermal growth factor |
| NGF | Nerve growth factor |
| TGF-α | Transforming growth factor alpha |
| TGF-β | Transforming growth factor bêta |
| HGF | Hepatocyte growth factor |
| IGF-I | Insulin-like growth factor 1 |
| IGF-II | Insulin-like growth factor 2 |
| bFGF | Basic fibroblast growth factor |
| EDC | Endocrine-disrupting chemical |
| AR | Androgen receptor |
| PR | Progesterone receptor |
| NP | Nonylphenol |
| BPA | Bisphenol A |
| ERα | Estrogen receptor alpha |
| CDK4 | Cyclin-dependent kinase 4 |
| IL-6 | Interleukin 6 |
| IL-1 | Interleukin 1 |
| BMI | Body mass index |
| VEGF | Vascular endothelial growth factor |
| IDDM | Insulin-dependent diabetes mellitus |
| NIDDM | Non-insulin-dependent diabetes mellitus |